Scarica l'app Stockscreener
0.3331
11.13%
-0.0417
Pre-mercato:
.33
-0.0031
-0.93%
Precedente Chiudi:
$0.3748
Aprire:
$0.3441
Volume 24 ore:
944.08K
Relative Volume:
1.21
Capitalizzazione di mercato:
$9.89M
Reddito:
$6.14M
Utile/perdita netta:
$-24.81M
Rapporto P/E:
-0.1338
EPS:
-2.49
Flusso di cassa netto:
$-27.40M
1 W Prestazione:
-19.21%
1M Prestazione:
-26.16%
6M Prestazione:
-67.66%
1 anno Prestazione:
-85.83%
Intervallo 1D:
$0.3267
$0.3515
Intervallo di 1 settimana:
$0.3267
$0.418
Portata 52W:
$0.3267
$2.75
Geovax Labs Inc Stock (GOVX) Company Profile
Nome
Geovax Labs Inc
Settore
Industria
Telefono
678-384-7220
Indirizzo
1900 LAKE PARK DRIVE, SMYRNA
Confronta GOVX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
0.3331 | 11.13M | 6.14M | -24.81M | -27.40M | -2.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-15 | Reiterato | Alliance Global Partners | Buy |
| 2025-04-15 | Reiterato | D. Boral Capital | Buy |
| 2024-11-11 | Iniziato | Alliance Global Partners | Buy |
| 2024-07-16 | Iniziato | ROTH MKM | Buy |
| 2020-11-19 | Iniziato | Maxim Group | Buy |
Geovax Labs Inc Borsa (GOVX) Ultime notizie
GeoVax’s Next-Generation COVID-19 Vaccine Shows Superior T-Cell Response in CLL Patients, Trial Advances Exclusively – citybuzz - citybuzz
GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients - Yahoo Finance
What drives GeoVax Labs Inc stock priceMarket Breadth Indicators & Buy Sell Timing Alerts - earlytimes.in
Published on: 2025-12-15 02:46:59 - earlytimes.in
New Mpox Variant Emergence Highlights Global Vaccine Supply Vulnerability, GeoVax Accelerates Domestic Alternative – citybuzz - citybuzz
GeoVax Addresses Identification of New Mpox Variant - TradingView — Track All Markets
GeoVax Strengthens Scientific Advisory Board with Global Vaccine Experts - citybuzz
GeoVax Announces Addition of Renowned Global Experts to Its Scientific Advisory Board - Yahoo Finance
GeoVax Announces Issuance of U.S. Patent Covering Enhanced Therapeutic Use of Gedeptin(R) Gene Therapy - Yahoo Finance
GeoVax’s Gedeptin Shows Favorable Safety and Disease Stability in Recurrent Head & Neck Cancer Trial - citybuzz
GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck Cancer - Yahoo Finance
Insider Sell: How GeoVax Labs Inc stock reacts to bond yieldsJuly 2025 Trends & Weekly Top Performers Watchlists - moha.gov.vn
An analyst sees good growth prospects for Geovax Labs Inc (GOVX) - setenews.com
Can GeoVax Labs Inc. Equity Warrant stock continue upward trendMarket Performance Report & Long-Term Capital Growth Ideas - Newser
What analysts say about GeoVax Labs Inc stockMarket Insider Reports & Low Risk Trading Ideas - earlytimes.in
Is This the Dip to Buy in Globus Spirits LimitedRisk Management Strategies & Free Discover Breakout Stocks Early - earlytimes.in
GeoVax Labs Earnings Call: Vaccine Progress Amid Financial Challenges - MSN
Will GeoVax Labs Inc. stock return to pre crisis levelsQuarterly Portfolio Report & Proven Capital Preservation Methods - Newser
Geovax Labs (GOVX) Stock Analysis Report | Financials & Insights - Benzinga
Update Recap: Why GeoVax Labs Inc. stock appeals to dividend seekersJuly 2025 Macro Moves & Entry Point Confirmation Alerts - moha.gov.vn
Returns Recap: Will GeoVax Labs Inc. stock outperform Nasdaq indexRate Hike & Reliable Breakout Forecasts - BỘ NỘI VỤ
GeoVax Labs Approves Share Issuance and Reverse Split - TipRanks
GeoVax to Present at the Noble Capital Markets Twenty-First Annual Emerging Growth Equity Conference - Yahoo Finance
GeoVax Labs Inc. (GOVX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
GeoVax Labs (NASDAQ:GOVX) Price Target Cut to $6.00 by Analysts at D. Boral Capital - Defense World
How resilient is GeoVax Labs Inc. Equity Warrant stock in market downturnsEarnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Should you wait for a breakout in GeoVax Labs Inc. Equity WarrantMarket Volume Report & Expert Curated Trade Setups - newser.com
Can GeoVax Labs Inc. Equity Warrant stock hit analyst price targetsStock Surge & Reliable Price Breakout Signals - newser.com
What technical charts say about GeoVax Labs Inc. stockBreakout Watch & Step-by-Step Swing Trade Plans - newser.com
Why GeoVax Labs Inc. stock is seen as undervaluedWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com
Can GeoVax Labs Inc. stock hit record highs againJuly 2025 Drop Watch & Smart Allocation Stock Reports - newser.com
Relative strength of GeoVax Labs Inc. Equity Warrant in sector analysisPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com
Custom watchlist performance reports with GeoVax Labs Inc.Dividend Hike & Safe Capital Growth Stock Tips - newser.com
Combining machine learning predictions for GeoVax Labs Inc. Equity WarrantJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Published on: 2025-11-19 17:57:21 - newser.com
How risky is GeoVax Labs Inc. Equity Warrant stock nowWeekly Stock Summary & Technical Confirmation Trade Alerts - newser.com
Real time breakdown of GeoVax Labs Inc. stock performanceQuarterly Portfolio Report & High Accuracy Buy Signal Tips - newser.com
Is now a turning point for GeoVax Labs Inc.July 2025 Trends & Community Consensus Picks - newser.com
Best data tools to analyze GeoVax Labs Inc. Equity Warrant stockWeekly Trade Report & Capital Efficient Trading Techniques - newser.com
Published on: 2025-11-19 13:22:17 - newser.com
D. Boral Capital Maintains GeoVax Labs (GOVX) Buy Recommendation - Nasdaq
Can technical indicators confirm GeoVax Labs Inc. Equity Warrant’s reversalRisk Management & Weekly Top Performers Watchlists - newser.com
GOVX Analyst Update: Price Target Lowered by Jason Kolbert | GOV - GuruFocus
Has GeoVax Labs Inc. found a price floorEntry Point & Precise Buy Zone Identification - newser.com
How to forecast GeoVax Labs Inc. trends using time series2025 EndofYear Setup & Verified Momentum Stock Alerts - newser.com
Published on: 2025-11-19 00:56:36 - newser.com
How GeoVax Labs Inc. Equity Warrant stock benefits from global expansionOptions Play & Weekly Chart Analysis and Guides - newser.com
Tools to monitor GeoVax Labs Inc. Equity Warrant recovery probabilityBuy Signal & Expert Approved Momentum Trade Ideas - newser.com
Is GeoVax Labs Inc. stock supported by strong fundamentalsPortfolio Update Summary & Weekly High Return Forecasts - newser.com
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX) and 4D Molecular Therapeutics (FDMT) - The Globe and Mail
Geovax Labs Inc Azioni (GOVX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Geovax Labs Inc Azioni (GOVX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SPENCER JOHN N JR | Director |
Apr 10 '25 |
Buy |
0.98 |
10,000 |
9,800 |
11,402 |
| Sharkey John W. | VP, Business Development |
Apr 10 '25 |
Buy |
0.99 |
6,000 |
5,940 |
6,191 |
| DODD DAVID A | President, CEO |
Apr 01 '25 |
Buy |
1.08 |
10,000 |
10,800 |
36,661 |
| Reynolds Mark | CFO |
Mar 31 '25 |
Buy |
1.08 |
6,800 |
7,343 |
14,013 |
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):